Cerus (CERS) Income from Non-Controlling Interests (2022 - 2026)
Cerus' (CERS) quarterly Income from Non-Controlling Interests came in at -$8000.0 in Q1 2026, down 700.0% year-on-year from $1333.3 in Q1 2025, and down 700.0% quarter-over-quarter from -$1000.0 in Q3 2025.
Cerus (CERS) Income from Non-Controlling Interests (2022 - 2026) Analysis & Trends
Cerus has disclosed Income from Non-Controlling Interests across 5 years of filings, most recently posting -$8000.0 for Q1 2026.
- Income from Non-Controlling Interests for Q1 2026 came in at -$8000.0, down 700.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$17000.0 (up 59.52% YoY), and the FY2025 annual result was -$10000.0, up 76.74% from the prior year.
- Income from Non-Controlling Interests came in at -$8000.0 for Q1 2026 at Cerus, down from -$1000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of -$1000.0 in Q4 2022 to a low of -$61000.0 in Q4 2023.
- The 5-year median for Income from Non-Controlling Interests is -$8000.0 (2025), against an average of -$20384.6.
- Across the five-year window, Income from Non-Controlling Interests tumbled 6000.0% in 2023 and jumped 90.91% in 2024, its largest moves.
- Cerus' Income from Non-Controlling Interests stood at -$1000.0 in 2022, then sank by 6000.0% to -$61000.0 in 2023, then jumped by 32.79% to -$41000.0 in 2024, then surged by 97.56% to -$1000.0 in 2025, then tumbled by 700.0% to -$8000.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at -$8000.0 (Q1 2026), -$1000.0 (Q3 2025), and -$8000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 100,000.00 |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | -8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -41,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -61,000.00 |
| Sep 30, 2023 | -19,000.00 |
| Jun 30, 2023 | -56,000.00 |
| Mar 31, 2023 | -22,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2022 | -39,000.00 |
| Jun 30, 2022 | -6,000.00 |